Association Between Early Clinical Responses and Long-Term Outcomes With Ruxolitinib Cream Treatment in Mild to Moderate Atopic Dermatitis. (2024). SKIN The Journal of Cutaneous Medicine, 8(2), s373. https://doi.org/10.25251/skin.8.supp.373